1. Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation. (18th April 2020) Authors: Shamriz, O; Simon, A J; Lev, A; Megged, O; Ledder, O; Picard, E; Joseph, L; Molho-Pessach, V; Tal, Y; Millman, P; Slae, M; Somech, R; Toker, O; Berger, M Journal: Clinical and experimental immunology Issue: Volume 200:Number 3(2020) Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗